Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 323 results for "zydus group cadila healthcare"

Cadila Healthcare launches Hepatitis C drug SoviHep
Odisha Samaya

Cadila Healthcare launches Hepatitis C drug SoviHep

New Delhi: Cadila Healthcare or Zydus Cadila has announced to launch an oral therapy SoviHep for the treatment of Hepatitis C. It is the Ahmedabad-based pharma major Cadila Healthcare has launched Hepatitis C drug and would be marketed by the ... Odisha Samaya, 1 month ago

6 images for zydus group cadila healthcare

India Infoline, 1 month ago
Money Control, 1 month ago
Odisha Samaya, 1 month ago
India Infoline, 1 month ago
Business Standard India, 2 months ago
Indian Express, 4 months ago

Zydus Group to Donate USD 240,000 to The National Institutes of Health, USA for Advancing Leishmaniasis Research

/PRNewswire/ -- Etna Biotech, the Vaccine R & D subsidiary of Zydus, announced a collaborative program with the National Institute of Allergy and Infectious Diseases, part of the U.S. National Institutes of Health, for advancing leishmaniasis ...
 Wall Street Business Network4 days ago

Cadila to Seek Investors' Nod to Raise up to Rs 10,000 Cr

New Delhi : Cadila Healthcare Ltd plans to seek "an enabling approval" from its shareholders to raise up to Rs 10,000 crore via issue of different securities. The company's board, which met on Wednesday, decided to seek shareholders' nod to issue ...
 NDTV Profit2 weeks ago Cadila to seek shareholders' nod to raise up to Rs 10,000 crore  Jagran Post2 weeks ago

Cadila Healthcare gains on announcing a collaborative program with the National Institute of Alle...

Cadila Healthcare is currently trading at Rs. 1755.80, up by 7.35 points or 0.42 % from its previous closing of Rs. 1748.45 on the BSE. The scrip opened at Rs. 1770.00 and has touched a high and low of Rs. 1770.00 and Rs. 1742.20 respectively. So ...
 Arihant Capital4 days ago Cadila Healthcare gains on inking non-exclusive licensing pact with Gilead Sciences  Arihant Capital1 month ago Zydus Cadila, Gilead Sciences ink non-exclusive licensing pact  Indian-Commodity1 month ago

Zydus ties up with US-based R&D to develop vaccine

Pharmaceuticals major Zydus today said that its R&D subsidiary Etna Biotech will collaborate with US-based National Institute of Allergy and Infectious Diseases (NIAD) to develop a vaccine against visceral leishmaniasis (VL), known as Kala-Azar in ...
 Hindu Business Line4 days ago Zydus ties up with US-based research centre to develop vaccine  Daily Excelsior.com3 days ago Zydus ties up with US-based RD centre to develop vaccine  Moneycontrol.com4 days ago
India Infoline

Cadila spurts 4% at opening bell

News Top News Top Story India Infoline News Service | Mumbai | March 18, 2015 09:36 IST New drug launch by Zydus group boosts sentiment at the counter. Cadila Healthcare spurted ...
 India Infoline1 month ago
Business Standard India

Capital International in talks to buy stake in Mankind Pharma

Secondary private equity transactions seem to be on the rise in India's healthcare space. Capital International, a global private equity (PE) fund, is learnt to be in talks to acquire a 11 per cent stake in Delhi-based Mankind Pharma for Rs ...
 Business Standard India2 months ago

Pharmaceutical Newsletter - April 06 to 10, 2015

Top News Dr. Reddy's Lab, Promius Pharma announces filing of three NDAs with USFDA Dr. Reddy's Laboratories and its subsidiary, Promius Pharma, LLC announced the filing of three 505(b)(2) New Drug Applications (NDAs) with the U.S. Food and Drug ...
 India Infoline2 weeks ago

Generic Drugs Market Forecast 2015-2025 Opportunities For Leading Companies

/PRNewswire/ -- Report Details Generic Drugs - new study showing you trends, R&D progress, and predicted revenues Where is the market for generic drugs heading? What are the commercial prospects for this market and related technologies? ...
 Tamar Securities2 weeks ago
Global Information Inc

Report Published "Global Small Cell Lung Cancer Therapeutics Market 2015-2019"

(MENAFN Press) Cancer occurs when after cell transformation normal cells grow and multiply without control. Lung cancer is a common cause of mortality and morbidity in developed and developing countries. Smoking is considered to be the major cause ...
 MENAFN3 weeks ago Global Small Cell Lung Cancer Therapeutics Market 2015-2019  MarketResearch.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - zydus group cadila healthcare
Get updated on latest news & your favorite topics right in your inbox!
More     Less